The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global OTC Veterinary Drug Market Research Report 2024

Global OTC Veterinary Drug Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1746528

No of Pages : 93

Synopsis
Over-the-counter (OTC) veterinary drugs are medications that can be purchased directly by pet owners without a prescription from a veterinarian. These medications are typically used for the treatment and management of minor health conditions in animals.
Global OTC Veterinary Drug market is projected to reach US$ 13890 million in 2029, increasing from US$ 8421 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Veterinary Drug market research.
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Veterinary Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type
Oral
Injectable
Topical
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The OTC Veterinary Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Veterinary Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectable
1.2.4 Topical
1.2.5 Others
1.3 Market by Application
1.3.1 Global OTC Veterinary Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Veterinary Drug Market Perspective (2018-2029)
2.2 OTC Veterinary Drug Growth Trends by Region
2.2.1 Global OTC Veterinary Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Veterinary Drug Historic Market Size by Region (2018-2023)
2.2.3 OTC Veterinary Drug Forecasted Market Size by Region (2024-2029)
2.3 OTC Veterinary Drug Market Dynamics
2.3.1 OTC Veterinary Drug Industry Trends
2.3.2 OTC Veterinary Drug Market Drivers
2.3.3 OTC Veterinary Drug Market Challenges
2.3.4 OTC Veterinary Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Veterinary Drug Players by Revenue
3.1.1 Global Top OTC Veterinary Drug Players by Revenue (2018-2023)
3.1.2 Global OTC Veterinary Drug Revenue Market Share by Players (2018-2023)
3.2 Global OTC Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Veterinary Drug Revenue
3.4 Global OTC Veterinary Drug Market Concentration Ratio
3.4.1 Global OTC Veterinary Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Veterinary Drug Revenue in 2022
3.5 OTC Veterinary Drug Key Players Head office and Area Served
3.6 Key Players OTC Veterinary Drug Product Solution and Service
3.7 Date of Enter into OTC Veterinary Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Veterinary Drug Breakdown Data by Type
4.1 Global OTC Veterinary Drug Historic Market Size by Type (2018-2023)
4.2 Global OTC Veterinary Drug Forecasted Market Size by Type (2024-2029)
5 OTC Veterinary Drug Breakdown Data by Application
5.1 Global OTC Veterinary Drug Historic Market Size by Application (2018-2023)
5.2 Global OTC Veterinary Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Veterinary Drug Market Size (2018-2029)
6.2 North America OTC Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Veterinary Drug Market Size by Country (2018-2023)
6.4 North America OTC Veterinary Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Veterinary Drug Market Size (2018-2029)
7.2 Europe OTC Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Veterinary Drug Market Size by Country (2018-2023)
7.4 Europe OTC Veterinary Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Veterinary Drug Market Size (2018-2029)
8.2 Asia-Pacific OTC Veterinary Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Veterinary Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Veterinary Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Veterinary Drug Market Size (2018-2029)
9.2 Latin America OTC Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Veterinary Drug Market Size by Country (2018-2023)
9.4 Latin America OTC Veterinary Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Veterinary Drug Market Size (2018-2029)
10.2 Middle East & Africa OTC Veterinary Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Veterinary Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Veterinary Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis OTC Veterinary Drug Introduction
11.1.4 Zoetis Revenue in OTC Veterinary Drug Business (2018-2023)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim OTC Veterinary Drug Introduction
11.2.4 Boehringer Ingelheim Revenue in OTC Veterinary Drug Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Virbac S.A.
11.3.1 Virbac S.A. Company Detail
11.3.2 Virbac S.A. Business Overview
11.3.3 Virbac S.A. OTC Veterinary Drug Introduction
11.3.4 Virbac S.A. Revenue in OTC Veterinary Drug Business (2018-2023)
11.3.5 Virbac S.A. Recent Development
11.4 Hester Biosciences Ltd.
11.4.1 Hester Biosciences Ltd. Company Detail
11.4.2 Hester Biosciences Ltd. Business Overview
11.4.3 Hester Biosciences Ltd. OTC Veterinary Drug Introduction
11.4.4 Hester Biosciences Ltd. Revenue in OTC Veterinary Drug Business (2018-2023)
11.4.5 Hester Biosciences Ltd. Recent Development
11.5 Merck Animal Health
11.5.1 Merck Animal Health Company Detail
11.5.2 Merck Animal Health Business Overview
11.5.3 Merck Animal Health OTC Veterinary Drug Introduction
11.5.4 Merck Animal Health Revenue in OTC Veterinary Drug Business (2018-2023)
11.5.5 Merck Animal Health Recent Development
11.6 Elanco Animal Health
11.6.1 Elanco Animal Health Company Detail
11.6.2 Elanco Animal Health Business Overview
11.6.3 Elanco Animal Health OTC Veterinary Drug Introduction
11.6.4 Elanco Animal Health Revenue in OTC Veterinary Drug Business (2018-2023)
11.6.5 Elanco Animal Health Recent Development
11.7 Ceva Santé Animale
11.7.1 Ceva Santé Animale Company Detail
11.7.2 Ceva Santé Animale Business Overview
11.7.3 Ceva Santé Animale OTC Veterinary Drug Introduction
11.7.4 Ceva Santé Animale Revenue in OTC Veterinary Drug Business (2018-2023)
11.7.5 Ceva Santé Animale Recent Development
11.8 Vetoquinol S.A.
11.8.1 Vetoquinol S.A. Company Detail
11.8.2 Vetoquinol S.A. Business Overview
11.8.3 Vetoquinol S.A. OTC Veterinary Drug Introduction
11.8.4 Vetoquinol S.A. Revenue in OTC Veterinary Drug Business (2018-2023)
11.8.5 Vetoquinol S.A. Recent Development
11.9 Phibro Animal Health Corporation
11.9.1 Phibro Animal Health Corporation Company Detail
11.9.2 Phibro Animal Health Corporation Business Overview
11.9.3 Phibro Animal Health Corporation OTC Veterinary Drug Introduction
11.9.4 Phibro Animal Health Corporation Revenue in OTC Veterinary Drug Business (2018-2023)
11.9.5 Phibro Animal Health Corporation Recent Development
11.10 Dechra Pharmaceuticals PLC
11.10.1 Dechra Pharmaceuticals PLC Company Detail
11.10.2 Dechra Pharmaceuticals PLC Business Overview
11.10.3 Dechra Pharmaceuticals PLC OTC Veterinary Drug Introduction
11.10.4 Dechra Pharmaceuticals PLC Revenue in OTC Veterinary Drug Business (2018-2023)
11.10.5 Dechra Pharmaceuticals PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’